Home » Topics » BioWorld Science

BioWorld Science
RSS

Esteve patents dual CACNA2D1/SIGMAR1 ligands

Dec. 22, 2021

Histone-lysine N-methyltransferase 2A inhibitors discovered at Novartis

Dec. 22, 2021

Chiesi identifies new discoidin domain-containing receptor inhibitors

Dec. 22, 2021

RET inhibitor SYHA-1815 induces G1 cell cycle arrest through c-MYC downregulation

Dec. 22, 2021

Extension of Series A financing at Ambys supports progression of AMI-918 for liver disease

Dec. 21, 2021

Choline transporter in fruit fly brain tunes out unnecessary information

Dec. 21, 2021

RaQualia and Hisamitsu to enter license agreement for sodium channel blocker

Dec. 21, 2021

Aridis' AR-701 is broadly reactive against Omicron and other SARS-CoV-2 variants

Dec. 21, 2021

IFI27 as a potential new gene biomarker for severe COVID-19

Dec. 21, 2021

FibroGen exercises license option for HiFiBiO's anti-CCR8 monoclonal antibody program

Dec. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...